Exclusive

Publication

Byline

Hospital chains to report steady growth in Q4, but there are challenges

New Delhi, April 25 -- Hospital chains are expected to report steady growth in the fourth quarter of FY25 (Q4FY25), driven by an increase in bed additions and higher revenue per bed, analysts said. Th... Read More


Demand for weight loss drugs is growing. Can wellness companies keep up?

New Delhi, April 17 -- US pharmaceutical company Eli Lilly launched its once-a-week weight loss injection Mounjaro in India last month, reigniting interest in weight loss solutions, this time with a m... Read More


Genetics can spike Indians' cholesterol, but relief may be at hand

New Delhi, April 14 -- The world's top pharmaceutical companies are developing drugs to lower a type of cholesterol common among Indians due to genetic factors, which may be launched in the country in... Read More


Sun Pharma can launch alopecia drug Leqselvi in US as court removes injunction

New Delhi, April 11 -- Sun Pharmaceutical Industries Ltd, which has been embroiled in a patent lawsuit in the US since last year over its specialty drug Leqselvi, received a favourable ruling from a c... Read More


Lupin's going beyond the pill to grow its digital therapeutics arm

New Delhi, April 8 -- Lupin Digital Health, drugmaker Lupin's digital therapeutics arm that focuses on cardiac rehabilitation and care, has doubled its patient base to 10,000 in the past year and expe... Read More


Indian pharma companies escape Trump's reciprocal tariffs, for now

Mumbai, April 3 -- India's pharmaceuticals sector, among the domestic industries most dependant on trade with the US, for now appears to have dodged the heavy reciprocal tariffs US President Donald Tr... Read More


Indegene sees tailwinds in the US, expanding in Europe

New Delhi, March 27 -- Bengaluru-based life sciences commercialisation firm Indegene sees significant headroom for growth in the US, its largest market, despite uncertainties around the new Trump regi... Read More


Wipro GE Healthcare rolls out $1 billion expansion plan; confident of dodging impact of reciprocal US tariffs

New Delhi, March 25 -- Wipro GE Healthcare, the 35-year-old joint venture between GE HealthCare and Wipro Enterprises, has started rolling out its $1 billion investment plan to expand manufacturing in... Read More


Mint Explainer: How big is the weight-loss drug market in India

New Delhi, March 24 -- It's not just for the celebrities anymore. The 'miracle' weight loss drug race has arrived in India with the launch of American drugmaker Eli Lilly's Mounjaro last week. Priced... Read More


Eli Lilly launches its blockbuster weight loss drug Mounjaro in India

Mumbai, March 21 -- US drugmaker Eli Lilly & Co. brought its anti-obesity drug Mounjaro to India on Thursday, marking the country's first treatment of its kind, with monthly costs ranging from Rs.14,0... Read More